141 related articles for article (PubMed ID: 15856622)
21. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
23. [Percutaneous coronary intervention in diabetic patients].
Lablanche JM; Rosey G; Zoubidi M; Sudre A
Bull Acad Natl Med; 2005 Feb; 189(2):249-56. PubMed ID: 16114856
[TBL] [Abstract][Full Text] [Related]
24. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
25. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA
Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
[No Abstract] [Full Text] [Related]
26. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?
Brodie BR
J Interv Cardiol; 2006 Feb; 19(1):43-50. PubMed ID: 16483339
[TBL] [Abstract][Full Text] [Related]
28. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
30. Contemporary treatment of coronary bifurcations with drug-eluting stent: part II.
Colombo A
J Interv Cardiol; 2006 Feb; 19(1):51-3. PubMed ID: 16483340
[No Abstract] [Full Text] [Related]
31. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
32. Optimizing percutaneous coronary intervention outcomes: the next steps.
Vetrovec GW
Circulation; 2005 Jan; 111(2):125-6. PubMed ID: 15657386
[No Abstract] [Full Text] [Related]
33. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
34. Stents and IIb/IIIa receptor blockers combined: usefulness in various types of coronary artery disease.
van der Wieken LR
Semin Interv Cardiol; 1999 Jun; 4(2):77-83. PubMed ID: 10473876
[TBL] [Abstract][Full Text] [Related]
35. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
37. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
38. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients.
Ruchin PE; Trabattoni D; Fabbiocchi F; Montorsi P; Lualdi A; Ravagnani P; Grancini L; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
Int J Cardiol; 2009 May; 134(2):231-7. PubMed ID: 18582971
[TBL] [Abstract][Full Text] [Related]
39. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]